President
Trump told reporters that he had discussed the issue with many people and found deep divisions, with some proponents of changing the drug’s status stressing its medical benefits while opponents said the move posed a risk to children.
“I’ve heard great things having to do with medical, and I’ve had bad things having to do with just about everything else but medical,” Trump said. “And, you know, for pain and various things, I’ve heard some ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.